These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 7780040)
1. Inhibition of cytokine activation processes in vitro by tenidap, a novel anti-inflammatory agent. McNiff PA; Laliberte RE; Svensson L; Pazoles CJ; Gabel CA Cytokine; 1995 Feb; 7(2):196-208. PubMed ID: 7780040 [TBL] [Abstract][Full Text] [Related]
2. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages. Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418 [TBL] [Abstract][Full Text] [Related]
3. Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. Sipe JD; Bartle LM; Loose LD J Immunol; 1992 Jan; 148(2):480-4. PubMed ID: 1729367 [TBL] [Abstract][Full Text] [Related]
4. Tenidap-modulated proinflammatory cytokine activation of a monocyte cell line. Golding S; Emery P; Young SP J Immunol; 1995 May; 154(10):5384-90. PubMed ID: 7730639 [TBL] [Abstract][Full Text] [Related]
5. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production. Matsumoto N; Aze Y; Akimoto A; Fujita T J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177 [TBL] [Abstract][Full Text] [Related]
6. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance. McNiff P; Svensson L; Pazoles CJ; Gabel CA J Immunol; 1994 Sep; 153(5):2180-93. PubMed ID: 8051419 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis. Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503 [TBL] [Abstract][Full Text] [Related]
8. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells. McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041 [TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes. Høgåsen AK; Hestdal K; Abrahamsen TG J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797 [TBL] [Abstract][Full Text] [Related]
10. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor. Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829 [TBL] [Abstract][Full Text] [Related]
11. Tenidap and other anion transport inhibitors disrupt cytolytic T lymphocyte-mediated IL-1 beta post-translational processing. Perregaux DG; Svensson L; Gabel CA J Immunol; 1996 Jul; 157(1):57-64. PubMed ID: 8683156 [TBL] [Abstract][Full Text] [Related]
12. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. Wanidworanun C; Strober W J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695 [TBL] [Abstract][Full Text] [Related]
13. Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells. Berger AE; Carter DB; Hankey SO; McEwan RN Eur J Immunol; 1993 Jan; 23(1):39-45. PubMed ID: 8419185 [TBL] [Abstract][Full Text] [Related]
14. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13. Levesque MC; Haynes BF J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421 [TBL] [Abstract][Full Text] [Related]
15. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. Goletti D; Kinter AL; Hardy EC; Poli G; Fauci AS J Immunol; 1996 May; 156(9):3501-8. PubMed ID: 8617979 [TBL] [Abstract][Full Text] [Related]
16. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures. Dimri R; Nissimov L; Keisari Y Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061 [TBL] [Abstract][Full Text] [Related]
17. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. Aderka D; Le JM; Vilcek J J Immunol; 1989 Dec; 143(11):3517-23. PubMed ID: 2584704 [TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia. Feder LS; Laskin DL J Leukoc Biol; 1994 Apr; 55(4):507-13. PubMed ID: 8145021 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages. Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537 [TBL] [Abstract][Full Text] [Related]
20. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. Janson RW; Hance KR; Arend WP J Immunol; 1991 Dec; 147(12):4218-23. PubMed ID: 1836481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]